Parathyroid Carcinoma Medication Savings with TheDrugClub
Members can check active-formulary eligibility and membership pricing for Parathyroid Carcinoma medications. A condition association alone does not establish coverage.
What Is Parathyroid Carcinoma?
Parathyroid Carcinoma is a medical condition that may require prescription treatment. Consult a healthcare professional about appropriate options.
Managing Parathyroid Carcinoma with TheDrugClub
Eligible medications linked to the active formulary may have no additional cost under listed supply, quantity, fill, and fulfillment limits. Other prescriptions may qualify for membership pricing. Confirm current terms before filling.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
About Parathyroid Carcinoma
Parathyroid carcinoma is a very rare and often aggressive cancer affecting the parathyroid glands, leading to dangerously high calcium levels. Managing this condition requires specialized care and often expensive medications. At TheDrugClub, we believe that access to vital treatments shouldn't be a financial burden, helping our members afford the prescriptions they need.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
About Parathyroid cancer (from MedlinePlus Genetics)
MedlinePlus Genetics covers Parathyroid Carcinoma in its summary of Parathyroid cancer.
Parathyroid cancer is a rare cancer that usually affects people in their forties or fifties and occurs in one of the four parathyroid glands. The parathyroid glands are located in the neck and secrete parathyroid hormone, which enhances the release of calcium into the blood.
In about 90 percent of cases, the early signs of parathyroid cancer are high levels of parathyroid hormone (hyperparathyroidism) and calcium (hypercalcemia) in the blood. In these cases, the cancer is described as hormonally functional because the parathyroid glands are producing excess hormone.
Many individuals with hormonally functional parathyroid cancer develop hypercalcemic crisis, in which calcium levels in the blood are very high. Neurological problems can develop, including changes in mood and depression. About 30 percent of individuals with hypercalcemia due to parathyroid cancer develop kidney and skeletal problems. These problems include increased urine production (polyuria), deposits of calcium in the kidneys (nephrocalcinosis) leading to the formation of kidney stones (nephrolithiasis), bone pain, bone loss, and increased bone fractures. Abdominal pain, inflammation of the pancreas (pancreatitis), sores (ulcers) in the lining of the digestive tract, nausea, vomiting, weight loss, and fatigue are also common.
About 10 percent of cases of parathyroid cancer are described as hormonally nonfunctional. In these cases, levels of parathyroid hormone and calcium are normal. The signs and symptoms of hormonally nonfunctional parathyroid cancer are related to the tumor obstructing nearby structures in the neck. These problems include difficulty swallowing (dysphagia) and speaking (dysarthria), a hoarse voice, shortness of breath (dyspnea), or vocal cord paralysis.
Up to 85 percent of individuals with parathyroid survive at least 5 years after they are diagnosed. The disease recurs in approximately half of individuals. If cancer does recur, it will commonly be within 3 years of the original diagnosis and up to 78 percent of people with recurrent cancer survive at least 5 years. Hormonally nonfunctional parathyroid cancer has a lower survival rate because it is often found at a later stage, as it does not have early signs such as increased calcium and parathyroid hormone levels.
In hormonally functional parathyroid cancer, death is usually caused by organ failure (usually kidney failure) due to prolonged hypercalcemia and not directly due to the tumor. In hormonally nonfunctional parathyroid cancer, the cause of death is typically related to the tumor itself, such as its impact on the function of nearby structures or its spread to other tissues (metastasis).
Source: MedlinePlus Genetics, U.S. National Library of Medicine
This information is educational and is not medical advice.
Medications used for Parathyroid Carcinoma
Talk with your doctor or pharmacist about which medication is right for you.